BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 18711242)

  • 1. Efficient use of continuous, real-time prostate localization.
    Malinowski KT; Noel C; Roy M; Willoughby T; Djemi T; Jani S; Solberg T; Liu D; Levine L; Parikh PJ
    Phys Med Biol; 2008 Sep; 53(18):4959-70. PubMed ID: 18711242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric and radiobiologic comparison of 3D conformal versus intensity modulated planning techniques for prostate bed radiotherapy.
    Koontz BF; Das S; Temple K; Bynum S; Catalano S; Koontz JI; Montana GS; Oleson JR
    Med Dosim; 2009; 34(3):256-60. PubMed ID: 19647638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric impact and theoretical clinical benefits of fiducial markers for dose escalated prostate cancer radiation treatment.
    Gauthier I; Carrier JF; BĂ©liveau-Nadeau D; Fortin B; Taussky D
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1128-33. PubMed ID: 19147306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observations on real-time prostate gland motion using electromagnetic tracking.
    Langen KM; Willoughby TR; Meeks SL; Santhanam A; Cunningham A; Levine L; Kupelian PA
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1084-90. PubMed ID: 18280057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin dose impact from vacuum immobilization device and carbon fiber couch in intensity modulated radiation therapy for prostate cancer.
    Lee KW; Wu JK; Jeng SC; Hsueh Liu YW; Cheng JC
    Med Dosim; 2009; 34(3):228-32. PubMed ID: 19647634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformal radiotherapy for detectable PSA following radical prostatectomy: efficacy and predictive factors of recurrence.
    Delongchamps NB; Zerbib M; Mejean A; Rouach Y; Debre B; Peyromaure M
    Can J Urol; 2009 Oct; 16(5):4813-9. PubMed ID: 19796456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assuring high quality treatment delivery in clinical trials - Results from the Trans-Tasman Radiation Oncology Group (TROG) study 03.04 "RADAR" set-up accuracy study.
    Haworth A; Kearvell R; Greer PB; Hooton B; Denham JW; Lamb D; Duchesne G; Murray J; Joseph D
    Radiother Oncol; 2009 Mar; 90(3):299-306. PubMed ID: 19017549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the dosimetric impact of non-exclusion of the rectum from the boost PTV in IMRT treatment plans for prostate cancer patients.
    Kassim I; Dirkx ML; Heijmen BJ
    Radiother Oncol; 2009 Jul; 92(1):62-7. PubMed ID: 19278745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of intrafraction prostate motion: accuracy of pre- and post-treatment imaging and intermittent imaging.
    Noel C; Parikh PJ; Roy M; Kupelian P; Mahadevan A; Weinstein G; Enke C; Flores N; Beyer D; Levine L
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):692-8. PubMed ID: 18692324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RapidArc volumetric modulated therapy planning for prostate cancer patients.
    Kjaer-Kristoffersen F; Ohlhues L; Medin J; Korreman S
    Acta Oncol; 2009; 48(2):227-32. PubMed ID: 18855157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
    Nieder AM; Porter MP; Soloway MS
    J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boost first, eliminate systematic error, and individualize CTV to PTV margin when treating lymph nodes in high-risk prostate cancer.
    Rossi PJ; Schreibmann E; Jani AB; Master VA; Johnstone PA
    Radiother Oncol; 2009 Mar; 90(3):353-8. PubMed ID: 18952307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Process control analysis of IMRT QA: implications for clinical trials.
    Pawlicki T; Yoo S; Court LE; McMillan SK; Rice RK; Russell JD; Pacyniak JM; Woo MK; Basran PS; Boyer AL; Bonilla C
    Phys Med Biol; 2008 Sep; 53(18):5193-205. PubMed ID: 18728311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Need for high radiation dose (>or=70 gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients.
    Cozzarini C; Montorsi F; Fiorino C; Alongi F; Bolognesi A; Da Pozzo LF; Guazzoni G; Freschi M; Roscigno M; Scattoni V; Rigatti P; Di Muzio N
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):966-74. PubMed ID: 19619960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-year follow-up of health-related quality of life after intensity-modulated radiation therapy for prostate cancer.
    Namiki S; Ishidoya S; Ito A; Tochigi T; Numata I; Narazaki K; Yamada S; Takai Y; Arai Y
    Jpn J Clin Oncol; 2009 Nov; 39(11):732-8. PubMed ID: 19666904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High precision transponder localization using a novel electromagnetic positioning system in patients with localized prostate cancer.
    Kindblom J; Ekelund-Olvenmark AM; Syren H; Iustin R; Braide K; Frank-Lissbrant I; Lennernäs B
    Radiother Oncol; 2009 Mar; 90(3):307-11. PubMed ID: 18952311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformal external beam radiotherapy in the treatment of anal canal carcinoma: a retrospective study of a genital organ sparing technique.
    Bui T; Harvey J; Brown E; Scott M; Haines T; Davidson K
    J Med Imaging Radiat Oncol; 2009 Aug; 53(4):396-404. PubMed ID: 19695047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of real-time internal electromagnetic position monitoring coupled with dynamic multileaf collimator tracking: an intensity-modulated radiation therapy feasibility study.
    Smith RL; Sawant A; Santanam L; Venkat RB; Newell LJ; Cho BC; Poulsen P; Catell H; Keall PJ; Parikh PJ
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):868-75. PubMed ID: 19394159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of colorectal cancer and prostate cancer and impact of radiation therapy.
    Huo D; Hetzel JT; Roy H; Rubin DT
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):1979-85. PubMed ID: 19531678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of percentage of positive prostate biopsy cores on biochemical outcome in low-risk PCa treated with brachytherapy or 3D-CRT.
    Pe ML; Trabulsi EJ; Kedika R; Pequignot E; Dicker AP; Gomella LG; Valicenti RK
    Urology; 2009 Jun; 73(6):1328-34. PubMed ID: 19376564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.